Goat anti-HEXIM1
EB06964
ApplicationsImmunoFluorescence, Western Blot, ELISA
Product group Antibodies
TargetHEXIM1
Overview
- SupplierEverest Biotech
- Product NameGoat anti-HEXIM1 Antibody
- Delivery Days Customer5
- Application Supplier NoteImmunofluorescence: Strong expression of the protein seen in the nucleus of A431 and HeLa cells. Recommended concentration: 10microg/ml.
- ApplicationsImmunoFluorescence, Western Blot, ELISA
- Applications SupplierPep-ELISA, IF, WB
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.5 mg/ml
- Gene ID10614
- Target nameHEXIM1
- Target descriptionHEXIM P-TEFb complex subunit 1
- Target synonymsCLP1, EDG1, HIS1, MAQ1, protein HEXIM1, HMBA-inducible, cardiac lineage protein 1, estrogen down-regulated gene 1 protein, hexamethylene bis-acetamide inducible 1, hexamethylene bis-acetamide-inducible protein 1, hexamethylene bisacetamide inducible 1, hexamethylene bisacetamide-inducible protein, hexamethylene-bis-acetamide-inducible transcript 1, hexamthylene bis-acetamide inducible 1, menage a quatre 1, menage a quatre protein 1
- HostGoat
- Scientific DescriptionRefSeq number(s): NP_006451.1. GeneIDs all Nonhuman: 192231 (mouse);. Purification: Antigen affinity purified. Names and symbols: HEXIM1; hexamethylene bis-acetamide inducible 1; HGNC:24953; CLP1; HIS1; MAQ1 ; HMBA-inducible; hexamethylene bisacetamide-inducible protein; hexamethylene-bis-acetamide-inducible transcript 1; hexamthylene bis-acetamide inducible 1; menage a quatre 1; ED
- Reactivity SupplierHuman, Mouse
- Storage Instruction-20°C
- UNSPSC12352203
References
- Bugai A, Quaresma AJC, Friedel CC, et al. P-TEFb Activation by RBM7 Shapes a Pro-survival Transcriptional Response to Genotoxic Stress. Mol Cell. 2019,74(2):254-267.e10. doi: 10.1016/j.molcel.2019.01.033Read this paper
- Blazek D, Teque F, Mackewicz C, et al. The CD8+ cell non-cytotoxic antiviral response affects RNA polymerase II-mediated human immunodeficiency virus transcription in infected CD4+ cells. J Gen Virol. 2016,97(1):220-224. doi: 10.1099/jgv.0.000326Read this paper




